HPLC column NUCLEODUR ® C 8 Gravity, 1.8 µm, 50 mm, 4.6 mm

Built to deliver predictable results in synthesis routines, the HPLC Column Nucleodur® C 8 Gravity, 1.8 μm, 50 mm, 4.6 mm features a high density C 8 phase based on high purity NUCLEODUR® silica gel. Its endcapping suppresses unwanted polar interactions between the silica surface and the sample, making it ideal for the separation of basic and other ionizable analytes. With an enhanced pH stability, LC/MS suitability, and superior base deactivation, this UHPLC column is a perfect choice for method development and valuable for RP applications. It comes packaged with an analytical HPLC column, instruction leaflet, and certificate of analysis.

• Category: Separation columns for HPLC
• Eluent in column: Acetonitrile - Water
• Temperature stability: 60 ° C
• Column volume: 0.83 ml
• Endcapped: yes
• Column type: UHPLC column
• Phase: C 8 Gravity
• Particle type: Fully porous particles (FPP)
• pH stability: 1,0-11,0
• L x Ø internal (column): 50 x 4.6 mm
• Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
• Pressure stability: 900 bar
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Specific surface according to BET: 340 m²/g
• Pore size: 110 Å
• Particle size: 1.8 µm
• Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
• Separation principle: Reversed phase (RP)
• Pore volume: 0.9 ml/g
• USP listing: L7
• Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
• Column shape: Analytical separation column